Tasly Tianjin Biopharmaceutical Co., Ltd.

Quick facts

Phase 2 pipeline

• ETV or TDF · Infectious Disease
  Inhibits viral replication

Phase 1 pipeline

• T101 Group
• T601

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Tasly Tianjin Biopharmaceutical Co., Ltd. portfolio CI brief
• Tasly Tianjin Biopharmaceutical Co., Ltd. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies